tiprankstipranks
Advertisement
Advertisement

SNDX Stock Latest News

Syndax price target lowered to $37 from $38 at UBS
The FlySyndax price target lowered to $37 from $38 at UBS
14d ago
SNDX
Syndax reports 12 Revuforj abstracts accepted for EHA
PremiumThe Fly
Syndax reports 12 Revuforj abstracts accepted for EHA
15d ago
SNDX
Syndax price target raised to $46 from $45 at Stifel
PremiumThe Fly
Syndax price target raised to $46 from $45 at Stifel
23d ago
SNDX
Syndax price target lowered to $37 from $40 at Jefferies
PremiumThe Fly
Syndax price target lowered to $37 from $40 at Jefferies
26d ago
SNDX
Analyst Reiterates Buy on Syndax as Commercial Momentum Builds and Clinical Data Strengthens, Maintains $40 Price Target
PremiumRatings
Analyst Reiterates Buy on Syndax as Commercial Momentum Builds and Clinical Data Strengthens, Maintains $40 Price Target
26d ago
SNDX
Syndax price target raised to $37 from $35 at Barclays
PremiumThe FlySyndax price target raised to $37 from $35 at Barclays
26d ago
SNDX
Phil Nadeau Reiterates Buy on Syndax, Citing Strong Revuforj Momentum, Longer Treatment Durations, and Emerging Niktimvo Upside
Premium
Ratings
Phil Nadeau Reiterates Buy on Syndax, Citing Strong Revuforj Momentum, Longer Treatment Durations, and Emerging Niktimvo Upside
26d ago
SNDX
Syndax reports Q1 EPS (48c), consensus (59c)
Premium
The Fly
Syndax reports Q1 EPS (48c), consensus (59c)
27d ago
SNDX
Syndax price target raised to $34 from $28 at Goldman Sachs
PremiumThe Fly
Syndax price target raised to $34 from $28 at Goldman Sachs
2M ago
SNDX
Syndax price target lowered to $43 from $45 at Mizuho
PremiumThe Fly
Syndax price target lowered to $43 from $45 at Mizuho
2M ago
SNDX
Syndax assumed with a Buy at Jefferies
PremiumThe Fly
Syndax assumed with a Buy at Jefferies
2M ago
KURA
SNDX
Syndax price target raised to $45 from $33 at JPMorgan
PremiumThe Fly
Syndax price target raised to $45 from $33 at JPMorgan
3M ago
SNDX
Syndax Pharmaceuticals’ Earnings Call Highlights Growth Push
PremiumCompany AnnouncementsSyndax Pharmaceuticals’ Earnings Call Highlights Growth Push
3M ago
SNDX
Syndax price target raised to $57 from $51 at Citi
Premium
The Fly
Syndax price target raised to $57 from $51 at Citi
3M ago
SNDX
Syndax reports Q4 EPS (78c), consensus (58c)
Premium
The Fly
Syndax reports Q4 EPS (78c), consensus (58c)
3M ago
SNDX
Syndax sees operating expense base remaining stable over next few years
PremiumThe Fly
Syndax sees operating expense base remaining stable over next few years
3M ago
SNDX
SNDX Upcoming Earnings Report: What to Expect?
PremiumPre-Earnings
SNDX Upcoming Earnings Report: What to Expect?
3M ago
SNDX
Syndax price target raised to $28 from $27 at BofA
PremiumThe Fly
Syndax price target raised to $28 from $27 at BofA
4M ago
SNDX
Syndax’s Revumenib Solid-Tumor Trial Completion: What Investors Should Watch Next
PremiumCompany Announcements
Syndax’s Revumenib Solid-Tumor Trial Completion: What Investors Should Watch Next
4M ago
SNDX
Syndax Pharmaceuticals: Strong Revuforj Momentum, Underappreciated Pipeline Catalysts Support Attractive Risk/Reward and Buy Rating
PremiumRatingsSyndax Pharmaceuticals: Strong Revuforj Momentum, Underappreciated Pipeline Catalysts Support Attractive Risk/Reward and Buy Rating
4M ago
SNDX
Syndax: Strong Revuforj and Niktimvo Momentum Undervalues Commercial Trajectory and Pipeline Upside
Premium
Ratings
Syndax: Strong Revuforj and Niktimvo Momentum Undervalues Commercial Trajectory and Pipeline Upside
4M ago
SNDX
Syndax Highlights Strong 2025 Results and Path to Profitability
Premium
Company Announcements
Syndax Highlights Strong 2025 Results and Path to Profitability
4M ago
8K
SNDX

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >